Phase 3 Study of KHK7580 (A Randomized, Double-Blind, Intra-Subject Dose-Adjustment, Parallel-Group Study of KHK7580 and Cinacalcet Hydrochloride in Subjects With Secondary Hyperparathyroidism Receiving Hemodialysis)
Phase of Trial: Phase III
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Evocalcet (Primary) ; Cinacalcet
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 23 Mar 2017 Status changed from recruiting to completed.
- 24 Sep 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 18 Sep 2015 New trial record